Estramustine

ADVERTISEMENT

Identification

Molecular formula
C23H31Cl2NO3
CAS Number
2998-57-4
IUPAC Name
[17-(1,5-dimethylhexyl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 2-[4-[bis(2-chloroethyl)amino]phenyl]acetate
Molecular Weight
598.49g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.3030g/cm3
Appearance
may vary based on specific formulation and batch characteristics in pharmaceutical preparations.
Synonyms
Fenesterin.
Interesting facts

Interesting Facts about the Compound

This fascinating compound is an excellent example of the complexity found within organic chemistry, exhibiting a rich structure that piques both scientific and educational interest. Below are some captivating details regarding this particular compound:

  • Structural Diversity: The compound showcases a unique blend of a steroid framework and an amino acid derivative, leading to a diverse array of potential interactions with biological systems.
  • Potential Biological Activity: Compounds similar to this one are often investigated for their potential therapeutic applications, particularly in treating various diseases, including cancer.
  • Synthetic Challenges: The synthesis of such complex molecules can be challenging, often requiring multiple steps and sophisticated techniques, which makes them intriguing subjects of study for chemistry students.
  • Relevance in Medicinal Chemistry: The presence of amino groups suggests potential reactivity with biological targets, making it a candidate for drug discovery and development.

As researchers work to unlock the secrets of this compound, it serves as a reminder of the creativity and precision required in chemistry. As one prominent scientist once stated, "Chemistry is the art of transformation; it turns the ordinary into the extraordinary." This compound epitomizes that very principle.

Overall, studying this compound not only expands our understanding of organic synthesis but also contributes to the ongoing quest for innovative therapeutic agents.

ADVERTISEMENT